Clinical Trials

230 enrolled

Brain Neoplasms, Radiation Injuries

NCT05805631 2026-03-24

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

Phase 2 Recruiting

23 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT05954416 2026-02-12

FARD

Recruiting

900 enrolled

Albinism, Ectodermal Dysplasia, Ichthyosis, Incontinentia Pigmenti, Keratoderma, Palmoplantar, Neurofibromatosis 1, Pemphigoid, Benign Mucous Membrane, Pemphigus

NCT07272616 2026-01-30

GDW

Recruiting

Brain Neoplasms

NCT06898684 2025-12-16

MOVE

15 enrolled

Medulloblastoma, Motor Activity

NCT07264569 2025-12-04

Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001

Phase 1/2 Recruiting

42 enrolled

Meningeal Carcinomatosis

NCT07224451 2025-11-04

BDF002

20 enrolled

Spinal Cord Neoplasms

NCT04324450 2025-09-04

IMPALA

Phase NA Completed

60 enrolled

Brain Neoplasms, Neoplasms

NCT02656407 2025-09-02

FUSIMAGINE

Phase NA Completed

23 enrolled

Brain Neoplasms

NCT07100600 2025-08-11

Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

Phase 2 Recruiting

224 enrolled

Brain Neoplasms

NCT04610229 2025-06-12

GLIORAD

Phase NA Completed

12 enrolled

Glioblastoma, Neoplasms

NCT05474573 2025-05-16

CONFLUENSE

52 enrolled

Brain Neoplasms, Glioma

NCT05475522 2025-05-16

SONOFLUO

Phase NA Suspended

134 enrolled

Brain Neoplasms, Glioma

NCT05477680 2025-05-16

BRASH

Arteriovenous Malformations, Brain Neoplasms, Cerebral Hemorrhage, Neoplasms, Hemangioma, Capillary

NCT05484219 2025-05-16

FUN

Phase NA Suspended

50 enrolled

Arteriovenous Malformations, Brain Neoplasms, Hemangioma, Capillary

NCT05484245 2025-05-16

SOMALI

Arteriovenous Malformations, Brain Neoplasms, Cerebral Hemorrhage, Hemangioma, Capillary

NCT05485038 2025-05-16

GAMMA

Phase NA Suspended

72 enrolled

Phase 2 Not yet recruiting

Brain Neoplasms, Glioma

NCT06971406 2025-05-14

FLAME-1